Among the tumours with reduced or absent Fhit expression, 72.2% (14 of 18) had loss of nuclear Mlh1 or Msh2 expression compared with only 20.6% (seven of 34) of the preserved or intermediate Fhit expression tumours (P<0.0001) (Table 2). The gene discussed is MLH1; the disease is neoplasm.